Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37143656)

  • 1. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
    Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
    Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
    Bao Q; Xu Y; Ding M; Chen P
    Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
    Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
    Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
    Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
    Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.
    Wen Y; Wang Y; Xing Z; Liu Z; Hou Z
    Cell Cycle; 2018; 17(24):2819-2832. PubMed ID: 30563416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.
    Yu WQ; Ji NF; Gu CJ; Sun ZX; Wang ZX; Chen ZQ; Ma Y; Wu ZZ; Wang YL; Wu CJ; Ding MD; Dai GH; Yao J; Jin RR; Huang M; Zhang MS
    Chin Med J (Engl); 2019 Nov; 132(22):2705-2715. PubMed ID: 31725455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis.
    Qiu S; Xie L; Lu C; Gu C; Xia Y; Lv J; Xuan Z; Fang L; Yang J; Zhang L; Li Z; Wang W; Xu H; Li B; Xu Z
    J Exp Clin Cancer Res; 2022 Oct; 41(1):296. PubMed ID: 36217165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
    Zhang X; Bao L; Yu G; Wang H
    Front Surg; 2022; 9():1050242. PubMed ID: 36684253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
    Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.
    Moradi-Chaleshtori M; Bandehpour M; Soudi S; Mohammadi-Yeganeh S; Hashemi SM
    Cancer Immunol Immunother; 2021 May; 70(5):1323-1339. PubMed ID: 33140190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion.
    Huang ZY; Shao MM; Zhang JC; Yi FS; Du J; Zhou Q; Wu FY; Li S; Li W; Huang XZ; Zhai K; Shi HZ
    Nat Commun; 2021 Nov; 12(1):6690. PubMed ID: 34795282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
    Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
    Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.
    Shojaee S; Romano G; Sanchez TM; Yermakhanova G; Saviana M; Le P; Nigita G; Calore F; Guthrie R; Hess K; Kang L; Swift-Scanlan T; Graham JT; Rahman NM; Nana-Sinkam PS; Acunzo M
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.
    Wang T; Lv M; Shen S; Zhou S; Wang P; Chen Y; Liu B; Yu L; Hou Y
    PLoS One; 2012; 7(8):e43268. PubMed ID: 22937028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA sequencing reveals immune microenvironment of small cell lung cancer-associated malignant pleural effusion.
    Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Chen M; Wen F
    Thorac Cancer; 2024 Jan; 15(1):98-103. PubMed ID: 38010064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
    Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
    Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.